Faculty Innovation

  • hive tech solutions truck on farm
    CU Boulder spinouts Ezalife, Hive Tech Solutions, and Mosaic received a total of $1 million in grants from the Colorado Office of Economic Development and International Trade (OEDIT)'s Advanced Industries Accelerator (AIA) Grant Program. A total of $8,567,756 was approved this grant cycle for Proof of Concept and Early-Stage Capital and Retention Grants to support Colorado’s advanced industries.
  • dna polymer
    Double helical covalent polymers—which are spiraling collections of nature’s building blocks—are fundamental to life itself, and yet, despite decades of research, scientists have never been able to synthesize them in their entirety like their non-helical brethren—until now. Scientists, led by a team at the ÀÖ²¥´«Ã½ Boulder, have cracked the code, creating synthetic versions of these large DNA-like molecules for the first time.
  • anushree chatterjee with researcher in lab
    Researchers at CU Boulder have created a platform that can develop effective and highly specific peptide nucleic acid therapies for use against any bacteria within just one week. The Facile Accelerated Specific Therapeutic (FAST) platform was created by Associate Professor Anushree Chatterjee and her team within the Department of Chemical and Biological Engineering.
  • nvc 14 specialty prize night winners
    More than 60 out of 110 registered NVC teams chose to participate in one of the three competitions: Impact Prize, NVC Newcomer Prize and Female Founder Prize. With inspiring and energetic programming, the Specialty Prize Nights gave attendees a preview of the startups who will be competing in the official NVC competition. The winners represented all corners of campus, ranging from the Leeds School of Business to the College of Music, to freshmen, graduate students, PhDs and faculty.
  • buff innovator insights logo
    The first episode of the inaugural season of Buff Innovator Insights, a new podcast from the Research & Innovation Office (RIO), will premiere on Thursday, March 18. The podcast will offer a behind-the-curtain look at some of the most ground-breaking innovations in the world—all emanating from the CU Boulder campus—along with the personal journeys that made those discoveries possible. New episodes will air each Thursday, from March 18 through May 6.
  • toy man on keyboard
    It’s inevitable that at some point we must all “get our affairs in order,†and when we do, there are checklists, policies and professionals to help create everything from wills and trusts to advance directives. But a key element––guidance surrounding technology and end-of-life planning––is missing, says Jed Brubaker, an assistant professor in Information Science.
  • dan caruso and cold quanta tech
    ColdQuanta, a CU Boulder spinout company co-founded by Physics Professor Dana Anderson, is a fast-growing startup focused on Cold Atom Quantum Technology, a scalable, versatile, and commercially viable area of quantum tech. Caruso’s involvement with the company began late last year, as he joined as an investor. After additional conversations with the leadership team, Caruso saw an opportunity to help.
  • research team in lab
    One by one, a team of often-siloed CU Boulder scientists began to pivot, back-burnering their own research and personal lives to face a daunting challenge: to bring 31,000 students back to campus safely in the midst of a deadly virus easily spread by young people who don’t know they have it.
  • longpath
    LongPath Technologies, Inc. has been awarded $5 million from the U.S. Department of Energy’s Advanced Research Projects Agency-Energy (ARPA-E). The award will support the commercial scaling of LongPath’s innovative approach to continuous emissions monitoring and mitigation from the oil and gas sector, including the launch of Basin-SCAN (Basin Scale Continuous oil and gas Abatement Network).
  • man and woman in lab
    OnKure, a privately-held biopharmaceutical company developing best-in-class, targeted oncology therapeutics, announced that it has raised $55 million in a Series B financing. Proceeds will be used to advance the Company’s next generation histone deacetylase (HDAC) inhibitors further into clinical development and fund a growing pipeline of earlier stage molecules.
Subscribe to Faculty Innovation